Caris Life Sciences (CAI) Accounts Payables (2024 - 2026)

Caris Life Sciences' Accounts Payables history runs 3 years deep, the most recent figure standing at $69.8 million for Q1 2026.

• In Q1 2026, Accounts Payables changed N/A year-over-year to $69.8 million; the TTM figure through Mar 2026 stood at $69.8 million (changed N/A YoY), while the FY2025 annual figure was $39.2 million, up 41.07% from the prior year.
• Accounts Payables was $69.8 million for Q1 2026 at Caris Life Sciences, up from $39.2 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $69.8 million in Q1 2026 to a low of $27.8 million in Q4 2024.
• Historically, Accounts Payables has averaged $38.9 million across 3 years, with a median of $29.0 million in 2025.
• Biggest YoY gain for Accounts Payables was 41.07% in 2025; the steepest drop was 41.07% in 2025.
• A 3-year view of Accounts Payables shows it stood at $27.8 million in 2024, then surged by 41.07% to $39.2 million in 2025, then surged by 78.04% to $69.8 million in 2026.
• The last three Accounts Payables figures came in at $69.8 million (Q1 2026), $39.2 million (Q4 2025), and $29.0 million (Q3 2025), per Business Quant data.